Lamivudine for hepatitis B after liver transplantation

被引：2
作者：
Mutimer, D [1 ]
机构：
[1] Queen Elizabeth Hosp, Liver & Hepatobiliary Unit, Birmingham B15 2TH, W Midlands, England
来源：
LIVER TRANSPLANTATION | 2001年 / 7卷 / 06期
关键词：
D O I：
10.1053/jlts.2001.24934
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：511 / 512
页数：2
相关论文
共 14 条
[1]   Lamivudine treatment for acute hepatitis B after liver transplantation [J].
Andreone, P ;
Caraceni, P ;
Grazi, GL ;
Belli, L ;
Milandri, GL ;
Ercolani, G ;
Jovine, E ;
D'Errico, A ;
Dal Monte, PR ;
Ideo, G ;
Forti, D ;
Mazziotti, A ;
Cavallari, A ;
Bernardi, M .
JOURNAL OF HEPATOLOGY, 1998, 29 (06) :985-989
[2]   Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients [J].
Benhamou, Y ;
Bochet, M ;
Thibault, V ;
Di Martino, V ;
Caumes, E ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (05) :1302-1306
[3]   Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation [J].
Herrero, JI ;
Quiroga, J ;
Sangro, B ;
Sola, I ;
Riezu-Boj, JI ;
Pardo, F ;
Prieto, J .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (06) :1186-1189
[4]   Lamivudine for hepatitis B in liver transplantation - A single-center experience [J].
Malkan, G ;
Cattral, MS ;
Humar, A ;
Al Asghar, H ;
Greig, PD ;
Hemming, AW ;
Levy, GA ;
Lilly, LB .
TRANSPLANTATION, 2000, 69 (07) :1403-1407
[5]   Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin [J].
Markowitz, JS ;
Martin, P ;
Conrad, AJ ;
Markmann, JF ;
Seu, P ;
Yersiz, H ;
Goss, JA ;
Schmidt, P ;
Pakrasi, A ;
Artinian, L ;
Murray, NGB ;
Imagawa, DK ;
Holt, C ;
Goldstein, LI ;
Stribling, R ;
Busuttil, RW .
HEPATOLOGY, 1998, 28 (02) :585-589
[6]   Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient [J].
Mutimer, D ;
Pillay, D ;
Shields, P ;
Cane, P ;
Ratcliffe, D ;
Martin, B ;
Buchan, S ;
Boxall, L ;
O'Donnell, K ;
Shaw, J ;
Hübscher, S ;
Elias, E .
GUT, 2000, 46 (01) :107-113
[7]   High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation [J].
Mutimer, D ;
Pillay, D ;
Dragon, E ;
Tang, H ;
Ahmed, M ;
O'Donnell, K ;
Shaw, J ;
Burroughs, R ;
Rand, D ;
Cane, P ;
Martin, B ;
Buchan, S ;
Boxall, E ;
Barmat, S ;
Gutekunst, K ;
McMaster, P ;
Elias, E .
JOURNAL OF HEPATOLOGY, 1999, 30 (04) :715-721
[8]   Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up [J].
Mutimer, D ;
Dusheiko, G ;
Barrett, C ;
Grellier, L ;
Ahmed, M ;
Anschuetz, G ;
Burroughs, A ;
Hubscher, S ;
Dhillon, AP ;
Rolles, K ;
Elias, E .
TRANSPLANTATION, 2000, 70 (05) :809-815
[9]   Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors [J].
Ono-Nita, SK ;
Kato, N ;
Shiratori, Y ;
Lan, KH ;
Yoshida, H ;
Carrilho, FJ ;
Omata, M .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (12) :1635-1640
[10]   Multicenter study of lamivudine therapy for hepatitis B after liver transplantation [J].
Perrillo, R ;
Rakela, J ;
Dienstag, J ;
Levy, G ;
Martin, P ;
Wright, T ;
Caldwell, S ;
Schiff, E ;
Gish, R ;
Villeneuve, JP ;
Farr, G ;
Anschuetz, G ;
Crowther, L ;
Brown, N .
HEPATOLOGY, 1999, 29 (05) :1581-1586
12